The Scientist Team at Dyno Therapeutics is responsible for leveraging advanced DNA technologies, computational science, deep learning, and experimental biology to engineer Adeno-associated Virus (AAV) capsids. Their work involves designing, testing, and refining new AAV variants to enhance the delivery and efficacy of gene therapies. This multidisciplinary team combines computational modeling and lab-based experiments to push the boundaries of gene therapy delivery systems.
View all